Pacific Biosciences of California Inc. (Nasdaq: PACB) will develop DNA sequencing systems and diagnostic products for Roche. The stock price leaped $2.52 to close at $5.98.
Pacific Biosciences To Develop Products For Roche
September 25, 2013 at 10:35 AM EDT
